992
Participants
Start Date
November 17, 2017
Primary Completion Date
January 31, 2021
Study Completion Date
January 31, 2021
Vortioxetine
Treatment with vortioxetine as per local SmPC
Asl Roma G (IT0005), Colleferro
Villa Von Siebenthal (IT0008), Roma
Azienda Ospedaliero-Universitaria San Luigi Gonzaga (IT0004), Orbassano
University Of Turin (IT0001), Turin
Clinique Mon Repos (FR0057), Marseille
Centre Hospitalier De Martigues (FR0064), Martigues
Finger Lakes Clinical Research (US0005), Rochester
Clinique Villa Bleue (FR0008), Angoulême
ASST Lodi (IT0042), Lodi
Azienda Ospedaliera San Paolo - Universita Degli Studi Di Milano (IT0014), Milan
Disturbi Depressivi Ospedale Luigi Sacco Polo Universitario Psichiatria 2 - CTDD (IT0033), Milan
Neuroscientific Insights (US0029), Rockville
Pneumology Clinic - AO San Gerardo (IT0017), Monza
Casa di Cura Villa San Benedetto Menni, Suore Ospedaliere (IT0025), Albese Con Cassano
ASST Papa Giovanni XXIII (IT0016), Bergamo
Università degli Studi di Brescia (IT0029), Brescia
CH De Novillars (FR0025), Chalezeule
Psichiatria Ospedale Oglio Po (IT0023), Cremona
Camp Antonin Artaud (FR0001), Quimper
Northwest Behavioral Research Center (US0007), Marietta
Centre Hospitalier Universitaire de Nimes (FR0018), Nîmes
Hopital De Psychiatrie (FR0009), Toulouse
Dr. David Modavi Md, Office Of (FR0034), Toulouse
Dr. Joel Pon MD, Office of (FR0027), Toulouse
Office Of Amit Vijapura, Md (US0057), Jacksonville
Sarkis Clinical Trials (US0066), Gainesville
Millenia Psychiatry and Research, Inc. (US0015), Orlando
Maxblue Institute (US0038), Hialeah
International Research Associates LLC (US0060), Miami
Da Vinci Research Institute (US0063), Boca Raton
Professional Health Care of Pinellas (US0050), St. Petersburg
Hopital de la Colombiere (FR0026), Montpellier
Harmonex Neuroscience Research Inc (US0072), Dothan
Psychiatric Consultants, Pc (US0028), Franklin
Hopital Albert Michallon- CHU Grenoble Alpes (FR0021), Grenoble
Centre Hospitalier De Blois (FR0011), Blois
Hopital Nord (FR0042), Saint-Priest-en-Jarez
CHU de Nantes (FR0023), Nantes
Quest Therapeutics Of Avon Lake (US0002), Avon Lake
Rochester Center For Behavioral Medicine (US0059), Rochester Hills
Dr. Philippe Remaud MD, Office of (FR0010), Angers
Chru Houtel Dieu (FR0020), Angers
Istituto di Neuroscienze (INS) (IT0028), Florence
Maison Des Addictions (FR0006), Nancy
Azienda Toscana nord ovest zona Apuane (IT0039), Massa
Ospedale Versilia (IT0002), Lucca
AMR- Baber Research, Inc. (US0006), Naperville
Southern Illinois Associates LLC (US0079), Glen Carbon
CHU Clermont-Ferrand, Hopital Gabriel Montpied (FR0037), Clermont-Ferrand
St. Charles Psychiatric Associates - Midwest Research Group (US0039), Saint Charles
DSM Giulianova - ospedale di Giulianova (IT0019), Giulianova
University Of Kansas Cancer Center (US0078), Kansas City
Dr Philippe Marmor, MD, Office of (FR0035), Strasbourg
Dr Lousqui Charles MD, Office of (FR0033), Strasbourg
Hopital civil (FR0039), Strasbourg
Cabinet Medical (FR0043), Mulhouse
Centre Hospitalier Bp29 (FR0015), Rouffach
Alivation Research, LLC (US0020), Lincoln
Meridian Clinical Research (US0027), Norfolk
CHS Le Vinatier (FR0013), Bron
Ospedali Riuniti Foggia (IT0007), Foggia
Dipartimento Salute Mentale ASL Lecce (IT0009), Lecce
Centre Hospitalier Sainte Anne (FR0029), Paris
Biopharma Informatic, LLC (US0031), Houston
Biopharma Informatic, LLC, Houston
West park Springs (US0073), Richmond
Bay Pointe Behavioral Health (US0030), Friendswood
Cmpi (FR0004), Le Vésinet
Centre Medical Ambroise Pare (FR0005), Élancourt
Cabinet Du Dr D Bonneau (FR0036), Thouars
Chs Philippe Pinel (Fr0017), Dury
Dr. Norbert Rigaud Md, Office Of (FR0028), Lamagistère
Centre Hospitalier Intercommunal Toulon - La Seyne sur Mer - Hôpital Sainte Musse (FR0019), Toulon
Clinique Korian La Crau (FR0063), La Crau
Pearl Health Clinic (US0001), Ammon
Center For Advanced Improvement (US0011), Tucson
Centre Hospitalier Esquirol (FR0038), Limoges
DSM Cosenza (IT0015), Cosenza
Universita Degli Studi Magna Graecia Di Catanzaro (IT0006), Catanzaro
North County Clinical Research (Nccr) (US0071), Oceanside
Breakthrough Clinical Trials (US0074), San Bernardino
Dr. Dominique Januel, MD Office of (FR0044), Rueil-Malmaison
Viking Clinical Research Center LLC (US0033), Temecula
Pharmacology Research Institute (US0045), Newport Beach
Unites De Soins Romain Rolland (FR0012), Saint-Denis
Clinique Clinea orgemont (FR0061), Argenteuil
Universita Degli Studi Di Catania - Azienda Policlinico (IT0030), Catania
Policlinico Universitario Di Messina (IT0031), Messina
Core Clinical Research (US0067), Everett
Chokka Center For Integrative Health (CA0001), Edmonton
Chatham-Kent Clinical Trials Research Centre (CA0007), Chatham
Queen's University-Hotel Dieu Hospital (CA0011), Kingston
St. Joseph's Health Care London - Parkwood Institute (Regional Mental Health Care London and Parkwood Hospital) (CA0004), London
Start Clinic For Mood And Anxiety Disorders (CA0006), Toronto
Jodha Tishon Inc (CA0008), Toronto
GCP Research (CA0013), Montreal
Mana Research Inc (CA0012), Point Claire
Alpha Recherche Clinique (CA0009), Québec
Alpha Recherche Clinique (CA0017), Québec
Centre Hospitalier Universitaire (CHU) de Nice - Hopital Pasteur - Clinique de Psychiatrie et de Psychologie Medicale (FR0041), Nice
Ospedale Sant'Andrea Hospital (IT0003), Rome
Insituto Di Ricovero E Cura A Carattere Scientifico San Raffaele Pisana (IT0035), Roma
Azienda Ospedaliera di Perugia - Policlinico Monteluce (IT0034), Perugia
Universita degli Studi di Roma La Sapienza - Umberto I Policlinico di Roma (IT0032), Roma
Universita Cattolica del Sacro Cuore (University of Sacred Heart Policlinico A. Gemelli) (IT0018), Rome
Ospedale Alfredo Fiorini (IT0026), Terracina
H. Lundbeck A/S
INDUSTRY